Tigermed To Merge With Jyton Group

Complementary advantages and development in coordination

Today, Hangzhou Tigermed Consulting Co., LTD issued an official announcement that Tigermed acquired 100% of Jyton Group’s shares, turning Jyton into a subsidiary of Tigermed.

Jyton Group is a wholly-owned holding company with five consulting services companies. Jyton, established in 1995, is the oldest and largest medical device consulting company in China, focusing mainly in medical devices, pharmaceuticals and regulations consulting, clinical trials, and recruiting services.

Through this acquisition, Tigermed can effectively expands its core business, specifically in the medical device industry, and improve customer service comprehensive ability. Jyton, through complementary advantages with Tigermed, receives more supports and opportunities to expand customer volume, improves business structure, and perfects technique competency, forming a rapid collaborative development pattern.           

About Tigermed

Hangzhou Tigermed Consulting Co., LTD, founded in 2004, is a contract research organization (CRO) dedicated to provide professional full clinical trial services in medical product development. Tigermed is committed to promote medical product development by reducing R&D risks and expenses, and at same time providing high-quality clinical trial services.

Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, with offices across 53 major cities in mainland China, and oversea offices spreading over Hong Kong, Taiwan, USA, Canada, Korea, Australia, Japan, Malaysia, Singapore, and India, employing nearly 2,000 full-time staff. Tigermed has successfully helped more than 600 clients conduct over 500 clinical trials. Involvement with approximately 57 innovative drug clinical trials earned Tigermed recognition as “an innovative CRO” in China. For more information about Tigermed, please visit www.tigermed.net.

About Jyton

Jyton, founded in 1995, is a renowned medical consultation service firm with integrated services in domestic and foreign medical device law and regulatory affairs, clinical trials, market services, and recruiting services. Jyton is the pioneer of medical device consultation services in China. Over the last 20 years, with a professional team consisting of nearly 200 employees, Jyton has successfully provided services to over 2,000 clients. In 2015, Jyton had sales revenue of close to $70 million, with a net profit of 30 million. Jyton’s main businesses concentrate on the medical devices field, providing an all-around solution service from product R&D to market entry, recruiting services, and market services. For more information about Jyton, please visit www.jtmedical.com.